Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta cir. bras ; 29(supl.1): 52-56, 2014. graf
Article Dans Anglais | LILACS | ID: lil-720400

Résumé

PURPOSE: To develop an alcoholic extract of the inner bark of the Schinus terebinthifolius raddi and to test its impact on autogenously fecal peritonitis in Wistar rats. METHODS: The inner bark of the Schinus terebinthifolius raddi was kept for seven days in 70% ethanol alcohol. The total elimination of the solvent was performed in a rotary evaporator under reduced pressure at 55-60°C. Four milliliter of this extract was injected, after 24 h, into the abdominal cavity of six out of eight survival rats that underwent autogenously fecal peritonitis with five milliliter of 10% filtered fecal suspension. They were clinically followed up for 45 days when they were euthanized. The necropsy findings (inventory) of the abdominal and thorax cavities were inspected and the main findings were recorded and photographed. The investigation was approved by the Ethics Committee. RESULTS: Two out of six survival rats that were critically ill after 24 h died within the 12 h after the extract injection into the abdominal cavity. Four rats that were also critically ill recovered and gradually became healthy, eating well, regaining weight and moving normally in the cage. At 45 days post severe peritonitis the necropsy findings revealed few signs of residual infection on the abdominal and thorax cavities. There were no bowel adhesions. CONCLUSION: The impact of alcoholic extract of the inner bark of the Schinus terebinthifolius raddi was considered very positive and promising as natural local antiseptic against very severe peritonitis in Wistar rats. .


Sujets)
Animaux , Mâle , Anacardiaceae/composition chimique , Anti-infectieux locaux/usage thérapeutique , Éthanol/usage thérapeutique , Maladies pulmonaires/traitement médicamenteux , Péritonite/traitement médicamenteux , Extraits de plantes/usage thérapeutique , Anti-infectieux locaux/isolement et purification , Maladies pulmonaires/étiologie , Illustration médicale , Péritonite/étiologie , Extraits de plantes/isolement et purification , Rat Wistar , Reproductibilité des résultats , Facteurs temps , Résultat thérapeutique
2.
Braz. j. microbiol ; 43(1): 235-242, Jan.-Mar. 2012. ilus, tab
Article Dans Anglais | LILACS | ID: lil-622808

Résumé

Staphylococcus epidermidis is the most frequent cause of nosocomial sepsis and catheter-related infections, in which biofilm formation is considered to be the main virulence mechanism. In biofilm environment, microbes exhibit enhanced resistance to antimicrobial agents. This fact boosted the search of possible alternatives to antibiotics. Farnesol and N-acetylcysteine (NAC) are non-antibiotic drugs that have demonstrated antibacterial properties. In this study, the effect of farnesol and NAC isolated or in combination (farnesol+NAC) was evaluated. NAC at 10 × MIC caused a total cell death in planktonic cells. On the other hand, S. epidermidis biofilms exhibited 4 log reduction in viable cell number after a 24h treatment with NAC at the former concentration. Our results demonstrated that there was a higher CFU log reduction of S. epidermidis planktonic cells when farnesol was combined with NAC at 1 × MIC relatively to each agent alone. However, these results were not relevant because NAC alone at 10 × MIC was always the condition which gave the best results, having a very high killing effect on planktonic cells and a significant bactericidal effect on biofilm cells. This study demonstrated that no synergy was observed between farnesol and NAC. However, the pronounced antibacterial effect of NAC against S. epidermidis, on both lifestyles, indicates the use of NAC as a potential therapeutic agent in alternative to antibiotics.


Sujets)
Humains , Acétylcystéine/isolement et purification , Anti-infectieux locaux/isolement et purification , Biofilms , Résistance microbienne aux médicaments , Infections à staphylocoques , Staphylococcus epidermidis/isolement et purification , Méthodologie , Patients , Virulence
SÉLECTION CITATIONS
Détails de la recherche